Anti-Cancer Effects of Human Placenta-Derived Amniotic Epithelial Stem Cells Loaded with Paclitaxel on Cancer Cells

Researchers investigated the appropriate condition of primming human amniotic epithelial cells (hAECs) with paclitaxel as a dual therapeutic approach consisting of inherent anticancer features of hAECs and loaded paclitaxel.